Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study

PURPOSE: To evaluate the impact of two different intraperitoneal (IP) chemotherapy regimens on progression-free survival (PFS) among women with newly diagnosed advanced ovarian carcinoma. METHODS: Eligible patients were randomly assigned to six cycles of IV paclitaxel 80 mg/m(2) once per week with i...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:J Clin Oncol
Κύριοι συγγραφείς: Walker, Joan L., Brady, Mark F., Wenzel, Lari, Fleming, Gini F., Huang, Helen Q., DiSilvestro, Paul A., Fujiwara, Keiichi, Alberts, David S., Zheng, Wenxin, Tewari, Krishnansu S., Cohn, David E., Powell, Matthew A., Van Le, Linda, Davidson, Susan A., Gray, Heidi J., Rose, Peter G., Aghajanian, Carol, Myers, Tashanna, Alvarez Secord, Angeles, Rubin, Stephen C., Mannel, Robert S.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society of Clinical Oncology 2019
Θέματα:
ORIGINAL REPORTS
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6544459/
https://ncbi.nlm.nih.gov/pubmed/31002578
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.01568
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια